GL1X · GenesisL1 explorer

MolNFT v1 · #28205 · protein

Solution structure of mlin-2/MLIN-7 L27 domain complex

1Y74 · Lin 7 homolog B: “Solution structure of mlin-2/MLIN-7 L27 domain complex”. Solution nmr, 1 pocket (best druggability 0.29). MolNFT v1 #28205 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1Y74
Type
protein
Length
214 residues
Chains
4
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lin 7 homolog B; Peripheral plasma membrane protein cask
EC
2.7.1.-
UniProt
O88951, O70589
Pockets
1 · best druggability 0.29

Structure

solution nmr · 2 distinct chains · 84% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CLin 7 homolog Bprotein5786% helix, 0% strandO88951
B, DPeripheral plasma membrane protein cask (EC 2.7.1.-)protein5082% helix, 0% strandO70589

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.290.7313empty

Interfaces

6 interfaces between chains.

  • A–D · 1259 Ų buried · 18 hydrogen bonds · protein-protein
  • B–C · 1180 Ų buried · 13 hydrogen bonds · protein-protein
  • A–C · 448 Ų buried · 0 hydrogen bonds · protein-protein
  • B–D · 243 Ų buried · 0 hydrogen bonds · protein-protein
  • A–B · 221 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 1Y74 · Solution Structure of mLin-2/mLin-7 L27 Domain Complex · the same entry in another collection · chain A against A, TM-score 1.00
  • O70589 · AlphaFold monomer V2.0 prediction for peripheral plasma membrane protein cask (O70589) · a predicted model of the same protein · chain B against A, TM-score 0.81
  • O88951 · AlphaFold monomer V2.0 prediction for protein lin-7 homolog B (O88951) · a predicted model of the same protein · chain A against A, TM-score 0.72

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.